InvestorsHub Logo
Followers 0
Posts 421
Boards Moderated 0
Alias Born 04/17/2018

Re: WordUP post# 13058

Tuesday, 05/15/2018 10:49:52 AM

Tuesday, May 15, 2018 10:49:52 AM

Post# of 18666
OXS-3550 for liquid tumors. The TRiKE platform has shown promising in vivo data compared to
BiKEs . (The addition of Il-15 created NK cell proliferation resulting in 60-70% remission vs 30-
50% for BiKE)

OXS-4550 Again using the TRiKE platform In Vivo data isn't yet, however Dr. Miller assured me in
the email that they've made significant progress with it.

OXS-4235 There's a chance (albeit slim) that this Multiple Myeloma drugs enters the clinic this
year
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News